期刊文献+

磷酸奥司米韦的合成 被引量:4

Synthesis of Oseltamivir Phosphate
下载PDF
导出
摘要 (–)-莽草酸经酯化、丙酮保护、甲磺酰化、缩酮交换、还原开环和闭环反应得中间体环氧化物,之后经叠氮开环氧、Staudinger反应合成氮丙啶中间体,然后再用叠氮开氮丙啶环、氨基乙酰化、还原叠氮基后与磷酸成盐得到抗流感病毒药磷酸奥司米韦。重点优化了丙酮保护、氮丙啶形成和叠氮还原3个步骤。避免了使用价格较贵的试剂,以及严格无水且易燃易爆的苛刻反应条件,总收率约为14%。 Starting from (-)-shikimic acid, oseltamivir phosphate was synthesized via twelve steps with an overall yield of about 14 %. Improvement was achieved in the ketalization, aziridine formatiom and azide reduction steps, avoiding the absolute anhydrous or potentially explosive conditions in the process.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2007年第6期393-397,共5页 Chinese Journal of Pharmaceuticals
基金 国家科技攻关项目流感防治药物研究与开发(2004BA51A67)
关键词 奥司米韦 抗流感药 合成 oseltamivir anti-influenza drug synthesis
  • 相关文献

参考文献8

  • 1Ward P,Small I,Smith J,et al.Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic[J].J Antimicrob Chemother,2005,55(Suppl.1):i5-i21.
  • 2The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5.Avian Influenza A (H5N1) Infection in Humans[J].New Engl J Med,2005,353(13):1374-1385.
  • 3Rchloff JC,Kent KM,Postich MJ,et al.Practical total synthesis of the anti-influenza drug GS-4104[J].J Org Chem,1998,63(13):4545-4550.
  • 4Federspiel M,Fischer R,Hennig M,et al.Industrial synthesis of the key precursor in the synthesis of the antiinfluenza drug oseltamivir phosphate(Ro 64-0796/002,GS-4104-02):ethyl(3R,4S,5S)-4,5-epoxy-3-(1-ethy1-propoxy)-cyclohex-1-ene-1-carboxylate[J].Org Proc Res Dev,1999,3(4):266-274.
  • 5于慧杰,周伟澄.磷酸奥司米韦合成路线图解[J].中国医药工业杂志,2006,37(1):66-69. 被引量:2
  • 6梅尔 HJ.将叠氮化物转变成酰胺的膦还原法:中国,1298868(2001-06-13)[J].CA,2001,135:6109-6109.
  • 7Dauban P,Chiaroni A,Riche C,et al.Synthesis of optically pure 3,4-disubstituted L-glutamates from a novel 2,3-aziridino-γ-lactone 4-carboxylate derivative[J].J Org Chem,1996,61(7):2488-2496.
  • 8Wang Z,Jimenez LS.Synthesis of an aziridinomitosene analog[J].J Org Chem,1996,61(2):816-818.

二级参考文献16

  • 1[1]Ward P,Small Ian,Smith,S,et al.Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic [J].J Antimicrob Chemother,2005,55 (Suppl.1):i5-i21.
  • 2[2]Brooks MJ,Sasadeusz JJ,Tannock GA.Antiviral chemothera peutic agents against respiratory viruses:where are we now and what's in the pipeline? [J].Curr Opin Pulm Med,2004,10 (3):197-203.
  • 3[3]Mendel DB,Roberts NA.In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors [J].Curr Opin in Infect Disease,1998,11 (6):727-732.
  • 4[4]Federspiel M,Fisher R,Hennig M,et al.Industrial synthesis of the key precursor in the synthesis of the anti-influenza drug oseltamivir phosphate (Ro 64-0796/002,GS-4104-02)ethyl (3R,4S,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate [J].Org Process Res Dev,1999,3(4):266-274.
  • 5[5]Bischofberger NW,Kim CU,Lew W,et al.Preparation of aminocyclohexenylcarboxylates and related compounds as neuraminidase inhibitors [P].US:5763483,1998-06-09.(CA1998,129:54135)
  • 6[6]Rohloff JC,Kent KM,Postich MJ,et al.Practical synthesis of the anti-influenza drug GS-4104 [J].J Org Chem,1998,63 (13):4545-4550.
  • 7[8]Terashima S,Ujita K,Kuwayama T,et al.Process for theproduction of 5-oxy-7-oxabicyclo-[4.1.0] hept-3-ene-3-carboxylic acid esters[P].WO:2001047906,2001-07-05.(CA 2001,135:76775)
  • 8[9]Stefan A,Martin K,Rene T,et al.Process for the preparation of Tamiflu and related 4,5-diaminoshikimic acid derivatives via Diels-Alder cycloaddition [P].EP:1127872,2001-08-29.(CA 2001,135:195452)
  • 9[10]Sugioka T,Ujita K,Kuwayama T,et al.Method for producing optically active 3-benzhydrylamine-4,5-dihydroxy-1cyclohecene-l-carboxylic acid ester[P].JP:2002088035,2002-03-27.(CA 2002,136:279213)
  • 10[11]Terashima S,Ujita K,Ishiwata A.Process for the preparation of 7-azabicyclo [4.1.0]-hept-3-ene-3-carboxylic acid esters[P].WO:2001032617,2001-05-10.(CA 2001,134:326392)

共引文献1

同被引文献49

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部